A new resource for studying how cancer drugs are absorbed and processed in the body
Official title: PITT-CAL ETCTN PK Resource Laboratory
Funded at Beckman Research Institute/city of Hope · NIH-11250285 · Data updated 2026-11-12
This study is all about working together to better understand how cancer drugs move through the body, so we can improve treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project start | January 1, 2025 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $472,785 |
| NIH project number | 7U24CA247643-06 |
| Project ID | NIH-11250285 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients participating in clinical trials of new anticancer drugs.
✕Less likely to help
Patients who are not currently undergoing cancer treatment or are not involved in clinical trials may not benefit from this research.
What this research studies
This research focuses on creating a collaborative laboratory resource to evaluate how anticancer drugs are absorbed, distributed, metabolized, and excreted in the body. By combining the expertise of two leading cancer pharmacology facilities, the project aims to enhance the understanding of drug behavior in patients undergoing treatment. The laboratory will analyze biological samples and perform detailed pharmacokinetic analyses to support the development of new cancer therapies. This integrated approach will help improve study designs and ensure timely reporting of results to clinical teams.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments tailored to individual patient needs.
How similar studies have gone: Previous research has shown success in pharmacokinetic studies of anticancer agents, indicating that this approach is both validated and promising.
Where this research is happening
-
Beckman Research Institute/city of Hope
Duarte, United States Active
Researchers
- Principal investigator: Synold, Timothy W — Beckman Research Institute/city of Hope
- Study coordinator: Synold, Timothy W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.